𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fluorescence analysis of competition of phenylbutazone and methotrexate in binding to serum albumin in combination treatment in rheumatology

✍ Scribed by M. Maciążek-Jurczyk; A. Sułkowska; B. Bojko; J. Równicka; W.W. Sułkowski


Book ID
108213033
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
690 KB
Volume
924-926
Category
Article
ISSN
0022-2860

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Competitive binding of phenylbutazone an
✍ A. Sułkowska; M. Maciążek-Jurczyk; B. Bojko; J. Równicka; I. Zubik-Skupień; E. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 280 KB

The binding sites for phenylbutazone and colchicine were identified in tertiary structure of bovine and human serum albumin with the use of spectrofluorescence analysis. It was found that phenylbutazone has two binding sites in both sera albumins (HSA and BSA), while colchicine has one binding site

Competition of drugs to serum albumin in
✍ Anna Sułkowska; Barbara Bojko; Joanna Równicka; Wiesław Sułkowski 📂 Article 📅 2004 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 264 KB 👁 2 views

## Abstract The mechanism of cooperative binding of both cytarabine and fluorouracil, used in combination therapy, to the transporting protein [bovine serum albumin (BSA)] has been investigated. Present study shows a strategy of estimating the kind of competition between these drugs with the use of

Competition of cytarabine and aspirin in
✍ Anna Sułkowska; Barbara Bojko; Joanna Równicka; Wiesław W. Sułkowski 📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 301 KB 👁 2 views

## Abstract The aim of this study was to describe a competition between cytarabine (araC) and aspirin (ASA) in binding with bovine serum albumin (BSA). High‐affinity binding sites for both drugs were determined using a spectrofluorimetric method. Cytarabine as well as aspirin binds in the IIA hydro

The competition of drugs to serum albumi
✍ A. Sułkowska; B. Bojko; J. Równicka; P. Rezner; W.W. Sułkowski 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Combination chemotherapy with cyclophosphamide (CM), metotrexate and 5-fluorouracil (FU) is used in treatment of patients with breast carcinoma. Although clinical toxicity of CM combinated with FU is greater than that of CM, the levels were clinically acceptable. The mechanism of competition of CM a